Compare Stocks: ILMN, QGEN, TMO, and IQV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ILMN Illumina	$201.27 -1.8%	$200.54	$88.00 ▼ $231.81	$30.96B	1.46	1.67 million shs	1.29 million shs
IQV IQVIA	$257.54 +0.2%	$235.44	$154.50 ▼ $271.80	$42.30B	1.18	1.21 million shs	1.32 million shs
QGEN Qiagen	$42.09 -1.0%	$42.15	$32.53 ▼ $57.81	$8.76B	0.63	2.75 million shs	1.25 million shs
TMO Thermo Fisher Scientific	$603.81 -0.3%	$578.63	$435.27 ▼ $647.00	$223.95B	0.85	1.58 million shs	1.55 million shs

10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ILMN Illumina	-1.82%	-9.20%	+4.37%	+25.04%	+110.78%
IQV IQVIA	+0.14%	-5.04%	+5.52%	+42.21%	+39.99%
QGEN Qiagen	-0.90%	-3.90%	-1.32%	+13.55%	-13.18%
TMO Thermo Fisher Scientific	-0.56%	-2.44%	-0.06%	+28.80%	+26.57%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ILMN Illumina	$201.27 -1.8%	$200.54	$88.00 ▼ $231.81	$30.96B	1.46	1.67 million shs	1.29 million shs
IQV IQVIA	$257.54 +0.2%	$235.44	$154.50 ▼ $271.80	$42.30B	1.18	1.21 million shs	1.32 million shs
QGEN Qiagen	$42.09 -1.0%	$42.15	$32.53 ▼ $57.81	$8.76B	0.63	2.75 million shs	1.25 million shs
TMO Thermo Fisher Scientific	$603.81 -0.3%	$578.63	$435.27 ▼ $647.00	$223.95B	0.85	1.58 million shs	1.55 million shs

10 Best Stocks to Own - Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ILMN Illumina	-1.82%	-9.20%	+4.37%	+25.04%	+110.78%
IQV IQVIA	+0.14%	-5.04%	+5.52%	+42.21%	+39.99%
QGEN Qiagen	-0.90%	-3.90%	-1.32%	+13.55%	-13.18%
TMO Thermo Fisher Scientific	-0.56%	-2.44%	-0.06%	+28.80%	+26.57%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ILMN Illumina	2.44	Hold	$199.13	-1.07% Downside
IQV IQVIA	2.88	Moderate Buy	$243.63	-5.40% Downside
QGEN Qiagen	2.43	Hold	$43.51	3.36% Upside
TMO Thermo Fisher Scientific	2.73	Moderate Buy	$624.64	3.45% Upside

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and IQV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/9/2026	TMO Thermo Fisher Scientific	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Hold ➝ Overweight
9/9/2026	TMO Thermo Fisher Scientific	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform
9/9/2026	TMO Thermo Fisher Scientific	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Market Perform
9/9/2026	TMO Thermo Fisher Scientific	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Overweight ➝ Underweight
9/9/2026	TMO Thermo Fisher Scientific	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Underperform
9/9/2026	TMO Thermo Fisher Scientific	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
9/9/2026	QGEN Qiagen	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$52.00 ➝ $47.00
9/9/2026	ILMN Illumina	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral ➝ Buy	$135.00 ➝ $260.00
9/8/2026	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$540.00 ➝ $730.00
9/3/2026	TMO Thermo Fisher Scientific	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	C$748.00
9/3/2026	ILMN Illumina	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$180.00 ➝ $235.00

(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ILMN Illumina	$4.34B	7.00	$6.59 per share	30.53	$17.82 per share	11.29
IQV IQVIA	$16.31B	2.60	$17.91 per share	14.38	$38.93 per share	6.62
QGEN Qiagen	$2.09B	4.15	$3.37 per share	12.48	$17.89 per share	2.35
TMO Thermo Fisher Scientific	$44.56B	5.01	$30.31 per share	19.92	$142.17 per share	4.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ILMN Illumina	$850M	$5.36	37.55	33.00	2.90	18.36%	29.84%	12.17%	10/29/2026 (Estimated)
IQV IQVIA	$1.36B	$8.06	31.95	19.96	2.19	8.10%	30.25%	6.54%	11/3/2026 (Estimated)
QGEN Qiagen	$424.88M	$1.95	21.57	15.42	4.23	19.49%	14.47%	8.34%	11/3/2026 (Estimated)
TMO Thermo Fisher Scientific	$6.70B	$18.59	32.48	21.95	2.53	15.04%	17.09%	8.12%	10/28/2026 (Estimated)

Latest ILMN, QGEN, TMO, and IQV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	QGEN Qiagen	$0.5980	$0.62	+$0.0220	$0.50	$527.50 million	$535.04 million
7/30/2026	Q2 2026	ILMN Illumina	$1.23	$1.31	+$0.08	$1.35	$1.13 billion	$1.16 billion
7/28/2026	Q2 2026	IQV IQVIA	$3.03	$3.15	+$0.12	$1.53	$4.30 billion	$4.37 billion
7/23/2026	Q2 2026	TMO Thermo Fisher Scientific	$5.71	$6.03	+$0.32	$4.68	$11.71 billion	$11.99 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ILMN Illumina	N/A	N/A	N/A	N/A	N/A
IQV IQVIA	N/A	N/A	N/A	N/A	N/A
QGEN Qiagen	$0.35	0.83%	N/A	17.95%	N/A
TMO Thermo Fisher Scientific	$1.88	0.31%	+14.34%	10.11%	8 Years

Latest ILMN, QGEN, TMO, and IQV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/9/2026	TMO Thermo Fisher Scientific	quarterly	$0.47	0.36%	9/15/2026	9/15/2026	10/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ILMN Illumina	0.53	1.80	1.40
IQV IQVIA	2.18	0.71	0.71
QGEN Qiagen	0.48	2.85	2.31
TMO Thermo Fisher Scientific	0.74	1.55	1.18

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ILMN Illumina	89.42%
IQV IQVIA	89.62%
QGEN Qiagen	70.00%
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
ILMN Illumina	2.90%
IQV IQVIA	1.70%
QGEN Qiagen	9.00%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ILMN Illumina	8,650	151.00 million	146.62 million	Optionable
IQV IQVIA	93,000	164.60 million	161.80 million	Optionable
QGEN Qiagen	5,654	206.07 million	187.53 million	Optionable
TMO Thermo Fisher Scientific	125,000	369.75 million	368.53 million	Optionable

ILMN, QGEN, TMO, and IQV Headlines

Recent News About These Companies

Thermo Fisher Scientific Inc. $TMO Shares Purchased by Engineers Gate Manager LP

55 minutes ago | marketbeat.com

Corient Private Wealth LP Trims Stake in Thermo Fisher Scientific Inc. $TMO

1 hour ago | marketbeat.com

Thermo Fisher stock gains analyst support as UBS lifts target to 730 dollars

September 10 at 6:57 PM | ad-hoc-news.deA

UBS sets $730 target on Thermo Fisher, a stock it just stopped doubting

September 10 at 6:57 PM | msn.com

Organoid Intelligence Market - Global Forecast to 2036; Biological Computing and Brain Organoids Drive Growth

September 10 at 8:41 AM | finance.yahoo.com

Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead

September 10 at 8:41 AM | finance.yahoo.com

National Pension Service Buys 12,295 Shares of Thermo Fisher Scientific Inc. $TMO

September 10 at 5:52 AM | marketbeat.com

28,360 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by WINTON GROUP Ltd

September 10 at 5:51 AM | marketbeat.com

Baird Financial Group Inc. Decreases Position in Thermo Fisher Scientific Inc. $TMO

September 10 at 3:12 AM | marketbeat.com

Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says

September 9 at 5:39 PM | finance.yahoo.com

Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls

September 9 at 12:38 PM | finance.yahoo.com

Thermo Fisher Scientific Inc. $TMO Shares Sold by C WorldWide Group Holding A S

September 9 at 7:11 AM | marketbeat.com

Waverly Advisors LLC Sells 5,199 Shares of Thermo Fisher Scientific Inc. $TMO

September 9 at 5:27 AM | marketbeat.com

13,900 Shares in Thermo Fisher Scientific Inc. $TMO Bought by VIRGINIA RETIREMENT SYSTEMS ET Al

September 9 at 5:12 AM | marketbeat.com

Allworth Financial LP Cuts Holdings in Thermo Fisher Scientific Inc. $TMO

September 9 at 3:03 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Holdings Boosted by Veritas Asset Management LLP

September 8 at 7:28 PM | marketbeat.com

Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others

September 8 at 3:17 PM | finance.yahoo.com

My Green Lab Expands ACT Ecolabel Channel Partner Network Ahead of New EU Environmental Claims Rules

September 8 at 3:17 PM | finance.yahoo.com

IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players

September 8 at 10:16 AM | finance.yahoo.com

Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus

September 8 at 9:35 AM | zacks.com

HighTower Advisors LLC Raises Holdings in Thermo Fisher Scientific Inc. $TMO

September 8 at 4:31 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and IQV Company Descriptions

Illumina NASDAQ:ILMN

$201.27 -3.73 (-1.82%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$201.59 +0.32 (+0.16%)

As of 05:16 AM Eastern

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

IQVIA NYSE:IQV

$257.54 +0.56 (+0.22%)

Closing price 09/10/2026 03:59 PM Eastern

Extended Trading

$255.99 -1.55 (-0.60%)

As of 04:19 AM Eastern

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Qiagen NYSE:QGEN

$42.09 -0.41 (-0.96%)

Closing price 09/10/2026 03:59 PM Eastern

Extended Trading

$42.41 +0.32 (+0.75%)

As of 05:02 AM Eastern

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Thermo Fisher Scientific NYSE:TMO

$603.80 -1.89 (-0.31%)

Closing price 09/10/2026 03:59 PM Eastern

Extended Trading

$617.00 +13.20 (+2.19%)

As of 05:14 AM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and IQV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ILMN, QGEN, TMO, and IQV Earnings

Compare Dividends

Latest ILMN, QGEN, TMO, and IQV Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ILMN, QGEN, TMO, and IQV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and IQV Company Descriptions

Illumina NASDAQ:ILMN

IQVIA NYSE:IQV

Qiagen NYSE:QGEN

Thermo Fisher Scientific NYSE:TMO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and IQV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ILMN, QGEN, TMO, and IQV Earnings

Compare Dividends

Latest ILMN, QGEN, TMO, and IQV Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ILMN, QGEN, TMO, and IQV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and IQV Company Descriptions

Illumina NASDAQ:ILMN

IQVIA NYSE:IQV

Qiagen NYSE:QGEN

Thermo Fisher Scientific NYSE:TMO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools